If a treatment is deemed safe and shows potential efficacy in Phase I, it progresses to Phase II trials. Phase II focuses on assessing the treatment's effectiveness in a larger group of patients and further examines safety. Successful Phase II trials can lead to Phase III trials, which compare the new treatment to standard therapies in even larger populations.
